Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Randomized Controlled Trial
100%
People Living with HIV (PLHIV)
100%
Early-onset Hypertension
100%
Haiti
100%
Prehypertension
87%
Cardiovascular Risk
50%
Standard of Care
37%
Systolic Blood Pressure
37%
Amlodipine
37%
Hypertension
25%
Diastolic Blood Pressure
25%
Antihypertensive Treatment
25%
Adverse Effects
12%
Cardiovascular Disease
12%
Viral Suppression
12%
Medication Adherence
12%
Low-middle Income Countries
12%
Difference in Mean
12%
Cardiovascular Mortality
12%
HIV Disease
12%
HIV Viral Suppression
12%
Follow Current
12%
Feasibility & Acceptability
12%
WHO Guidelines
12%
Blood Pressure Treatment
12%
BP Threshold
12%
Qualitative In-depth Interviews
12%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Randomized Controlled Trial
100%
Prehypertension
70%
Cardiovascular Disease
50%
Systolic Blood Pressure
30%
Amlodipine
30%
Arm
20%
Diastolic Blood Pressure
20%
Antihypertensive Therapy
20%
Blood Pressure
10%
Medication Compliance
10%
Adverse Effect
10%
Primary Outcome
10%
Nursing and Health Professions
Human Immunodeficiency Virus
100%
Prehypertension
70%
Cardiovascular Disease
50%
Systolic Blood Pressure
30%
Health Care Quality
30%
Amlodipine
30%
Diastolic Blood Pressure
20%
Antihypertensive Therapy
20%
Blood Pressure
10%
Practice Guideline
10%
Medication Compliance
10%
World Health Organization
10%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
HIV
100%
Prehypertension
70%
Cardiovascular Disease
50%
Amlodipine
30%
Antihypertensive Agent
20%